Latest fromStock Takes
Stock Takes: Why a $4 billion deal fell over
The failed Ebos deal would have been a big bite for investors.
Stock Takes: What’s eating Fisher & Paykel Healthcare?
Since June 30, Fisher & Paykel Healthcare's stock has fallen by 14 per cent.
Pipe nightmare: Fletcher Building shares expected to fall
The company's pipe business has turned into a nightmare.
Stock Takes: Synlait’s big reveal, Fisher and Paykel's investor day
More light will be shed on the state of play with cash-strapped Synlait Milk on Monday.
Stock Takes: High interest rates versus stocks
High interest rates are making their presence felt on NZ share prices.
The economic conditions the next Government will have to contend with
How much can an incoming government afford?
New Xero CEO reveals biggest competition, AI experiments
The US-based chief executive says she's made hard choices already.
Why this reporting season poses a 'conundrum' for profitable companies
Reporting season is set to serve up a few interesting earning results.
Stock Takes: Call for Pacific Edge board shake-up
Plus: Vend's financial result under new ownership.
Fix or float? Keys to the RBNZ’s next OCR move
An economist's best guess of the RBNZ’s next rate move.
'NZ is in a tough patch': Why our economy is looking like the US during the GFC
Fisher Funds' Ashley Gardyne weighs in on how markets have performed.
'Make money, or be right? - an investor’s recession dilemma
A market bull picks recession-proof stocks.
Auckland airport share sale: Ratepayers could end up being short-changed
Council's compromise might have just delivered Aucklanders the worst of two worlds.
Why is there such a dearth of companies listing on the NZX?
It has been months since the last listing on the NZ Stock Exchange.
Stock Takes: Aussies line up for Good Spirits bars
Plus: Michael Wood's mixed bag of shares, and life after Marsden Point.
How this NZ pharma firm prices drugs to avoid villain status
This NZ drug maker says it puts health above wealth.
No easy fix for high inflation environment
Fisher Funds portfolio manager Matt Peek talks about the impact of the Budget.
A capital raise for Synlait - or something more radical for balance sheet woes?
Stock Takes: Is the underperforming Synlait Milk heading toward another capital raise?
‘A rounding error’: Why Govt’s $4b Budget boost doesn’t signal big spend-up
The no-frills Budget needs to focus on the basics.
Is it time to list Ports of Auckland on share market?
A new report has highlighted some problems with local government ownership.